• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Johns Hopkins Arthritis Center

Show Search
Hide Search
  • Disease Information
    • Rheumatoid Arthritis
    • Psoriatic Arthritis
    • Ankylosing Spondylitis
    • Osteoarthritis
    • Gout
    • Osteoporosis
  • Patient Corner
    • Drug Information Sheets
    • Managing Your Arthritis
    • RheumTV – Patient Education Video Library
  • Our Research
    • Patient-Centered Outcomes Research
    • Current Research Studies
    • The Camille Julia Morgan Arthritis Research and Education Fund
  • About Us
    • Appointment Information
    • Contact Us
    • Our Faculty
    • Our Staff
    • Rheumatology Specialty Centers
    • News & Updates
  • Donate
Home / Ask the Expert / Rheumatoid Arthritis and Shingles

Rheumatoid Arthritis and Shingles

May 13, 2011 By Clifton Bingham, III, MD

Question

I have been successfully treated for Rheumatoid Arthritis for the last 20 years. Currently on the Enbrel drug among others. Just recently, I have developed a spot of Shingles on the back of my neck. I am treating it also, however, is there a pronounced connection to Enbrel treatment and the appearance to Shingle?

Answer

Shingles represents the reactivation of a previous viral infection with Herpes Zoster, the cause of Chicken Pox.  Many adults have had infection with chicken pox as a child.  Risk factors including aging and immunosuppression can lead to the reactivation of the virus usually along the course of a single nerve from the spine.  Symptoms typically begin with a burning and painful sensations restricted to an area, with the formation of small blisters that then crust over.  This can be extremely debilitating pain, and when it occurs on the face and around the eye can even threaten vision.  Because this can occur in patients with immunosuppressive drugs, we do see a number of RA patients who have this problem when taking DMARDS, including nonbiological and biological drugs. The most important thing is recognition of the early symptoms because medications (such as acyclovir, famcyclovir) can shorten the duration and decrease longer term consequences if started early enough.  Because of the risk of shingles, immunizations to prevent recurrence are recommended for patients BEFORE starting biological agents.  This is a live virus vaccine that can potentially cause problems in patients on too much immunosuppression.  The Centers for Disease control  notes that the vaccine can be given to patients taking prednisone (up to 20 mg/day) and methotrexate.  

Clifton Bingham, III, MD

Professor of Medicine
Director - Johns Hopkins Arthritis Center

Primary Sidebar

Ask The Expert Topics

  • Alternative Therapies
  • Ankylosing Spondylitis
  • Associated With Other Illnesses
  • Bursitis and Tendinitis
  • Corticosteroids
  • Diet and Exercise
  • Disease Modifying Antirheumatic Drugs (DMARDs)
  • Enteropathic Arthritis
  • Fibromyalgia
  • General Arthritis
  • Gout, Pseudogout, Other
  • Infectious Arthritis
  • Myositis
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  • Osteoarthritis
  • Osteonecrosis
  • Osteoporosis
  • Polymyalgia Rheumatica
  • Psoriatic Arthritis
  • Reactive Arthritis
  • Regional Pain: Back and Neck
  • Rehabilitation
  • Rheumatoid Arthritis
  • Surgical Therapy
  • Systemic Lupus Erythematosus (SLE)
  • Systemic Sclerosis
  • Vasculitis
RheumTV Logo

Rheum.TV is an informational platform created to educate patients living with a rheumatic disease. With over 100 disease education videos produced by the team at Johns Hopkins Rheumatology.

Visit Rheum.TV

Footer

Johns Hopkins Rheumatology

  • Johns Hopkins Rheumatology
  • Johns Hopkins Lupus Center
  • Johns Hopkins Lyme Disease Research Center
  • Johns Hopkins Myositis Center
  • Johns Hopkins Scleroderma Center
  • Johns Hopkins Sjögren’s Syndrome Center
  • Johns Hopkins Vasculitis Center

Connect With Us

  • Facebook
  • Twitter
  • YouTube

Johns Hopkins Medicine

© 2025 Johns Hopkins Arthritis Center
Patient Privacy